FFIV
45
4
EQR
44
-3
CF
42
-6
SO
53
-4
GILD
47
-2
NTAP
67
2
ZION
61
-2
CHD
35
3
BEN
48
2
KMB
42
-3
CVX
37
6
EQIX
59
5
GE
62
-3
NRG
52
-8
AON
56
-4
CTAS
36
8
PRU
76
14
AVGO
31
5
CCI
41
5
ABBV
50
-7
FFIV
45
4
EQR
44
-3
CF
42
-6
SO
53
-4
GILD
47
-2
NTAP
67
2
ZION
61
-2
CHD
35
3
BEN
48
2
KMB
42
-3
CVX
37
6
EQIX
59
5
GE
62
-3
NRG
52
-8
AON
56
-4
CTAS
36
8
PRU
76
14
AVGO
31
5
CCI
41
5
ABBV
50
-7
Financhill
Back

Haemonetics Corp. Stock Price Chart

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
68

HAE
Haemonetics Corp.

Last Price:
$83.94
Seasonality Move:
-0.44%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HAE is experiencing slight selling pressure.

Haemonetics Corp. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 81.77 Buy
20-day SMA: 77.13 Buy
50-day SMA: 61.17 Buy
200-day SMA: 63.71 Buy
8-day EMA: 81.45 Buy
20-day EMA: 75.77 Buy
50-day EMA: 66.86 Buy
200-day EMA: 65.17 Buy

Haemonetics Corp. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.51 Buy
Relative Strength Index (14 RSI): 90.58 Buy
Chaikin Money Flow: -216400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.81 - 83.09) Buy
Bollinger Bands (100): (48.41 - 72.35) Buy

Haemonetics Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Haemonetics Corp. Stock

Is Haemonetics Corp. Stock a Buy?

  • Haemonetics Corp. share price is 83.94 while HAE 8-day simple moving average is 81.77, which is a Buy signal.
  • The stock price of HAE is 83.94 while Haemonetics Corp. 20-day SMA is 77.13, which makes it a Buy.
  • Haemonetics Corp. 50-day simple moving average is 61.17 while HAE share price is 83.94, making it a Buy technically.
  • HAE stock price is 83.94 and Haemonetics Corp. 200-day simple moving average is 63.71, creating a Buy signal.

HAE Technical Analysis vs Fundamental Analysis

Buy
68
Haemonetics Corp. (HAE) is a Buy

Is Haemonetics Corp. a Buy or a Sell?

  • Haemonetics Corp. stock is rated a Buy
    The current Haemonetics Corp. [HAE] share price is $83.94. The Score for HAE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.

Haemonetics Corp. Stock Info

Market Cap:
3.9B
Price in USD:
83.94
Share Volume:
746.2K

Haemonetics Corp. 52-Week Range

52-Week High:
85.23
52-Week Low:
47.32
Buy
68
Haemonetics Corp. (HAE) is a Buy

Haemonetics Corp. Share Price Forecast

Is Haemonetics Corp. Stock a Buy?

  • Haemonetics Corp. share price is 83.94 while HAE 8-day exponential moving average is 81.45, which is a Buy signal.
  • The stock price of HAE is 83.94 while Haemonetics Corp. 20-day EMA is 75.77, which makes it a Buy.
  • Haemonetics Corp. 50-day exponential moving average is 66.86 while HAE share price is 83.94, making it a Buy technically.
  • HAE stock price is 83.94 and Haemonetics Corp. 200-day simple moving average is 65.17, creating a Buy signal.

Fundamental Analysis of Haemonetics Corp.

Is Haemonetics Corp. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.37 per share.

Technical Analysis of Haemonetics Corp.

Should I short Haemonetics Corp. stock?

* Haemonetics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.